About Cheilbio
Cheilbio is a company based in Yongin (South Korea) founded in 1977. Cheilbio offers products and services including Resume Writing Service, Cover Letter Samples, and Online Consultation. Cheilbio operates in a competitive market with competitors including Zoetis, Ceva, Bio-Sourcing, Phage Lab and Proteon Pharmaceuticals, among others.
- Headquarter Yongin, South Korea
- Stage Public
-
Sectors
HealthcareAgriculture
-
Phone
Locked
-
Website
Locked
- Legal Name Cheil Bio Co., Ltd.
-
Annual Revenue
$9.43 M (USD)41.59as on Dec 31, 2024
-
Net Profit
-$282.43 K (USD)71.19as on Dec 31, 2024
-
EBITDA
-$493.84 K (USD)64.53as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cheilbio
Cheilbio is a publicly listed company on the KRX with ticker symbol 052670 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cheilbio
Cheilbio offers a comprehensive portfolio of products and services, including Resume Writing Service, Cover Letter Samples, and Online Consultation.
Professional assistance for creating tailored resumes for job applications.
Provides sample templates for effective job application letters.
Offers guidance on career documents via online platforms.
Funding Insights of Cheilbio
Detailed funding history for Cheilbio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cheilbio
Investment portfolio details for Cheilbio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cheilbio
Detailed financials for Cheilbio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cheilbio Comparisons
Peer comparison for Cheilbio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cheilbio
Cheilbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, Bio-Sourcing, Phage Lab and Proteon Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Animal health therapeutics are developed and supplied globally by Ceva.
|
|
| Locked | Locked | Locked |
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
|
|
| Locked | Locked | Locked |
Bacteriophage treatments for animal infections are developed by the company.
|
|
| Locked | Locked | Locked |
Therapeutics for animal infectious diseases are developed via phage platforms.
|
|
| Locked | Locked | Locked |
Proprietary monoclonal antibody platform is provided for pig intestinal infections.
|
Detailed competitors of Cheilbio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cheilbio
Complete news archive for Cheilbio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cheilbio
Cheilbio was founded in 1977.
Cheilbio is headquartered in Yongin, South Korea. It is registered at Yongin, Gyeonggi, South Korea.
Gwang Gyeong Shim is the current CEO of Cheilbio.
Annual revenue of Cheilbio is $9.43M as on Dec 31, 2024.
The company was founded in 1977 and focuses on the livestock health sector. Disease prevention solutions and treatment aids are developed through research and development efforts. Therapeutic products, including antifungal antibiotics and colistin strains used as feed additives, have been created. Diagnostic kits for chicken salmonella antibodies via ELISA and parvovirus detection through immunochromatography are provided. Complex probiotic enzymes are produced from designated waste clay.
Cheilbio's top competitors include Zoetis, Ceva and Bio-Sourcing.
Cheilbio offers Resume Writing Service, Cover Letter Samples, and Online Consultation.
Yes, Cheilbio is publicly traded on KRX under the ticker symbol 052670.
The ticker symbol of Cheilbio is 052670 on KRX.